Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02028689 · ClinicalTrials.gov registry record · Phase 1
Metformin and Furosemide Drug-Drug Interaction Study
A Phase 1 study, sponsored by Ardea Biosciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 23
- Enrollment target
NCT02028689 is a Phase 1 study that has completed, run by Ardea Biosciences. The registered enrollment target is 23 participants.
The verdict
NCT02028689, a Phase 1 study, has completed, sponsored by Ardea Biosciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 23 participants
- Enrollment target
Study Summary
This study will assess the potential effects of lesinurad on the pharmacokinetics (PK) of metformin and furosemide in healthy, adult male subjects.
Interventions
- DRUG Furosemide 40 mg
- DRUG Lesinurad 400 mg
- DRUG Metformin 850 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2013-10 |
| Est. Completion | 2014-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02028689
The ClinicalTrials.gov registry entry for NCT02028689 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ardea Biosciences, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Furosemide 40 mg is the first listed.
NCT02028689 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02028689 about?
NCT02028689 is a clinical study titled "Metformin and Furosemide Drug-Drug Interaction Study". This study will assess the potential effects of lesinurad on the pharmacokinetics (PK) of metformin and furosemide in healthy, adult male subjects.
What is the current status of trial NCT02028689?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2013-10. Estimated completion is 2014-01.
What interventions are being tested in trial NCT02028689?
The interventions under investigation include: Furosemide 40 mg (DRUG), Lesinurad 400 mg (DRUG), Metformin 850 mg (DRUG).
Who is sponsoring clinical trial NCT02028689?
This trial is sponsored by Ardea Biosciences, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.